Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Correction to : Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H 2 Mab-250/H 2 CasMab-2 for Breast Cancers’’ by Kaneko et al. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 2024;43(2):35–43;doi: 10.1089/mab.2023.0033